Kolexia
Blaise Lorraine Gastro-entérologie
Blaise Lorraine
Gastro-entérologie
Hôpital Jean Verdier
Bondy, France
51 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome hépatocellulaire Carcinomes Tumeurs du foie Cirrhose du foie Maladies du foie Hémorragie COVID-19 Varices oesophagiennes et gastriques Fibrose

Collaborateurs

Voir plus
Nault Jean-Charles
Nault Jean-Charles
Hôpital Jean Verdier, Bondy, France
Carrie Nathalie
Carrie Nathalie
Hôpital Jean Verdier, Bondy, France
Nahon Pierre
Nahon Pierre
Hôpital Jean Verdier, Bondy, France
Seror Olivier
Seror Olivier
Hôpital Jean Verdier, Bondy, France

Industries

Voir plus
Ipsen
1 collaboration(s)
Dernière en 2022
Gilead
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma.
Liver international : official journal of the International Association for the Study of the Liver   04 mars 2024
No correlation between MASLD and poor outcome of Atezolizumab-Bevacizumab therapy in patients with advanced HCC.
Liver international : official journal of the International Association for the Study of the Liver   30 janvier 2024
The liver in sickle cell disease.
Presse medicale (Paris, France : 1983)   20 novembre 2023
Impact of radiological response and pattern of progression in patients with hepatocellular carcinoma treated by atezolizumab- bevacizumab.
Hepatology (Baltimore, Md.)   23 octobre 2023
Endoscopic ultrasound-guided glue injection for refractory bleeding from gastric varices: A safe and effective therapeutic option (with video).
Clinics and research in hepatology and gastroenterology   09 septembre 2023
Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCC.
Clinics and research in hepatology and gastroenterology   02 septembre 2023
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?
Annals of hepatology   17 juillet 2023
Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinoma.
Alimentary pharmacology & therapeutics   09 juin 2023
Atezolizumab plus bevacizumab in advanced hepatocellular carcinoma after treatment failure with multikinase inhibitors.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   03 avril 2023
Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular Carcinoma.
Journal of hepatocellular carcinoma   28 décembre 2022